Ostroumova O.D., Telkova S.S., Dubinina A.V., Klepikova M.V., Kochetkov A.I.
Non-alcoholic fatty liver disease as a trigger of polymorbidity. Is there a way out of the impasse?
|
№4 / 2024
|
E.A. Mezikova, V.D. Zavadovskaya, E.V. Beloborodova, I.V. Dolgalev, O.S. Tonkikh
Multislice computer tomography perfusion imaging of the hepatosplenic zone in patients with diffuse liver diseases
|
№2 / 2019
|
Yu.G. Sandler (1), A.V. Polukhina (1), E.V. Vinnitskaya (1), I.G. Bakulin (2), Zh.V. Borunova (1), V.A. Keyyan (1)
PROGNOSTIC SIGNIFICANSE OF THE POLYMORPHISM OF GENES ASSOCIATED WITH THE RISK OF TYPE 2 DIABETES MELLITUS AND OBESITY, FOR THE DEVELOPMENT OF LIVER FIBROSIS AND HEPATIC STEATHOSIS IN PATIENTS WITH NON-ALCOHOLIC FAT LIVER DISEASE
|
№s5-17 / 2017
|
I.G. Bakulin, Yu.V. Medvedev
13C METHACETIN BREATH TEST FOR THE EVALUATION OF LIVER FUNCTIONAL RESERVES
|
№s5-16 / 2016
|
M.Yu. Galushko (1), I.G. Bakulin (2), A.I. Timokhina (1)
COMPARATIVE ANALYSIS OF THE DIAGNOSIS OF LIVER FIBROSIS BY M- AND XL-ELASTOMETRY IN PATIENTS WITH CHRONIC HEPATITIS C.
|
№s5-16 / 2016
|
I.G. Bakulin, E.V. Vinnytskaya, Yu.G. Sandler, V.A. Keiyan, S.V.Rodionova
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
|
№2 / 2016
|
Andreev D.N., Maev I.V., Dicheva D.T., Kucheryavy Yu.A., Partsvania-Vinogradova E.V.
ANALYSIS OF INFLUENCE OF LIVER FIBROSIS ON EFFICACY AND SAFETY OF ANTI-HELICOBACTER THERAPY
|
№20 / 2015
|
A.N. Surkov
MODERN POTENTIALS FOR THE DIAGNOSIS AND TREATMENT OF LIVER CIRRHOSIS IN CHILDREN
|
№1 / 2015
|
E.V. Vinnitskaya , Yu.M. Yunusova
Liver Fibrosis: Potentials For The Regression
|
№13 / 2012
|
N.B. Gubergritc, P.G. Fomenko, G.M. Lukashevich, O.A. Golubova
Pharmacological Effects And Clinical Features Of The Reference Preparation Silymarin
|
№2 / 2012
|
I.V. Majev, T.E. Polunina, E.V. Polunina
Rational Approach To Diagnostics And Treatment Of Chronic Viral Hepatitis C
|
№11 / 2009
|